2021
DOI: 10.1016/j.ejmech.2021.113803
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of new human Sirtuin 5 inhibitors by mimicking glutaryl-lysine substrates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
45
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(48 citation statements)
references
References 34 publications
1
45
0
Order By: Relevance
“…The 3-thioureidopropanoic acid derivative 13e is the most potent and selective, with an IC 50 value of 3.0 μM and no activity toward SIRT1–3 or SIRT6 at 600 μM. 169 This molecule has been obtained in the context of a medicinal chemistry campaign aimed at finding glutaryl-lysine mimicking molecules. Unfortunately, no biological data have been provided, hence it is unclear whether this class of molecules may have any cellular effect and in which context they may be useful.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The 3-thioureidopropanoic acid derivative 13e is the most potent and selective, with an IC 50 value of 3.0 μM and no activity toward SIRT1–3 or SIRT6 at 600 μM. 169 This molecule has been obtained in the context of a medicinal chemistry campaign aimed at finding glutaryl-lysine mimicking molecules. Unfortunately, no biological data have been provided, hence it is unclear whether this class of molecules may have any cellular effect and in which context they may be useful.…”
Section: Discussionmentioning
confidence: 99%
“…Another study identified SIRT5 inhibitors by joining a heteroaromatic ring to a 3-thioureidopropanoic acid warhead through an aminoethyl linker to mimic the interactions of ε- N -glutaryllysine within the SIRT5 active site. 169 Among the synthesized molecules, compounds 13a and 13b bearing a pyridine scaffold and a 2-benzylamino substitution, respectively, were about threefold less potent than compound 13c (IC 50 (desuccinylation) = 9.6 μM), where pyridine was replaced by pyrimidine ( Table 5 ). Starting from 13c , various modifications were performed to gain SAR information.…”
Section: Pharmacological Modulation Of Sirt5mentioning
confidence: 99%
See 1 more Smart Citation
“…The same research group also synthesized some cyclic derivatives of 30 , which are reported in the next section [ 52 ]. Recently, Yang et al prepared a series of 3-thioureidopropanoic acid derivatives mimicking glutaryl-lysine substrates [ 53 ]; among them, 31 ( Figure 7 ) showed promising inhibitory activity and selectivity for SIRT5 (IC 50 = 3.0 μM, SIRT1-3,6 IC 50 > 600 μM) [ 53 ].…”
Section: Sirt5 Modulatorsmentioning
confidence: 99%
“…The same research group also synthesized some cyclic derivatives of 30, which are reported in the next section [52]. Recently, Yang et al prepared a series of 3-thioureidopropanoic acid derivatives mimicking glutaryl-lysine substrates [53]; among them, 31 (Figure 7) showed promising inhibitory activity and selectivity for SIRT5 (IC50 = 3.0 μM, SIRT1-3,6 IC50 > 600 μM) [53]. Among a series of compounds bearing the thiourea warhead reported by Rajabi et al, 32 (Figure 8) exhibited the most potent and selective SIRT5-inhibitory activity (IC50 = 0.11 μM) [54].…”
Section: Synthetic Compoundsmentioning
confidence: 99%